Stopping GLP-1 Drugs Linked to Higher Cardiovascular Risk in Type 2 Diabetes

A study found that people with type 2 diabetes who stopped GLP-1 treatment had about twice the combined risk of heart attack, stroke or death compared with those who continued treatment.

Comments

Read this story in other languages

de fr it es tr nl

Covered by the press in 4 countries

Among the outlets we follow

Netherlands1
Spain1
Switzerland1
United States1

Stopping GLP-1 Drugs Linked to Higher Cardiovascular Risk in Type 2 Diabetes

Comments

Covered by the press in 4 countries

Similar News from External Sources

DOWNLOAD OUR APP